PDPL Intraday Analysis...

PDPL Share Price

Open 11.45 Change Price %
High 11.80 1 Day 0.20 1.75
Low 11.40 1 Week -1.15 -8.98
Close 11.65 1 Month -3.55 -23.36
Volume 2172 1 Year -12.35 -51.46
52 Week High 28.80
52 Week Low 11.20
PDPL Important Levels
Resistance 2 12.02
Resistance 1 11.87
Pivot 11.62
Support 1 11.43
Support 2 11.28
NSE INDIA Most Active Stocks
JPASSOCIAT 15.65 4.33%
RCOM 14.15 -0.35%
TATAMOTORS 288.65 -6.72%
ONGC 167.70 -4.39%
SBIN 268.50 2.01%
NCC 114.40 8.69%
NCC 114.40 8.69%
PCJEWELLER 188.00 -4.54%
ASHOKLEY 144.50 -0.58%
ADANIPOWER 18.90 -5.97%
More..
NSE INDIA Top Gainers Stocks
GREENFIRE 0.30 20.00%
EROSMEDIA 142.15 19.55%
SHALPAINTS 136.60 15.27%
ORTEL 18.35 11.55%
SUJANAUNI 0.50 11.11%
EON 66.10 9.98%
STINDIA 14.35 9.96%
LAKSHMIEFL 16.80 9.80%
CENTEXT 5.95 9.17%
VASWANI 13.35 8.98%
More..
NSE INDIA Top Losers Stocks
VISESHINFO 0.10 -33.33%
INGERRAND 626.25 -28.40%
RAJRAYON 0.20 -20.00%
SPYL 0.25 -16.67%
FCSSOFT 0.25 -16.67%
TDPOWERSYS 158.50 -15.24%
BIGBLOC 118.00 -13.20%
ARIES 161.90 -9.98%
MCDHOLDING 31.55 -9.34%
GET&D 331.70 -8.43%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 5
As on 24th May 2018 PDPL Share Price closed @ 11.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 19.11 & Strong Sell for SHORT-TERM with Stoploss of 15.41 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for May
1st Target up-side 16.93
2nd Target up-side 19.09
3rd Target up-side 21.25
1st Target down-side 10.77
2nd Target down-side 8.61
3rd Target down-side 6.45
PDPL Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) N/A N/A
RSI (14) RSI is 31.16 Sideways
MFI (14) MFI is 33.79 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 13.89
10 Day Avg Volume Traded -65.73 % Less then 10 Day Average Volume
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.